The genomic sequencing conducted on 42 swab specimens in Nepal found that 97.6 per cent had been infected with Delta variants while the remaining 2.4 per cent with Alpha variants.
The Delta variant doubles the risk of hospitalisation compared with the Alpha variant first found in the UK, but Pfizer and AstraZeneca vaccines provide good protection against the strain, says a study published in The Lancet journal.
